Kiyohiro Sakai
Osaka, 5898511, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pregabalin for Opioid-resistant Neuropathic Pain in Bone Metastases.
Journal: Anticancer research
Published: February 18, 2026
Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.
Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.
Journal: Molecular and clinical oncology
Published: September 03, 2024
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.
Journal: Oncology letters
Published: March 16, 2023
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
Journal: The oncologist
Published: June 22, 2022
Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study.
Journal: BMJ supportive & palliative care
Published: November 28, 2021
Clinical Characteristics of Noncancer-Related Upper Back Pain on Initiation of Palliative Care in Patients with Incurable Cancer.
Journal: Palliative medicine reports
Published: October 29, 2021
Clinical characteristics of alexisomia in patients with incurable cancer.
Journal: Annals of palliative medicine
Published: June 05, 2021
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 09, 2019
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Journal: Journal of pain and symptom management
Published: May 08, 2019
Avoiding diagnostic errors in psychosomatic medicine: a case series study.
Journal: BioPsychoSocial medicine
Published: November 28, 2017
Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer.
Journal: Biomedical reports
Published: March 15, 2017
Expectation of a Decrease in Pain Affects the Prognosis of Pain in Cancer Patients: a Prospective Cohort Study of Response to Morphine.
Journal: International journal of behavioral medicine
Published: March 08, 2017
Last Updated: 09/26/2026